戻る Agenda
Session 6: Free Session - Choose Between:
Speaker(s)
Session 6 – Value, Access & Regulatory Evidence Workshop: Joint Clinical Assessment (REA)
Claudine Sapède, PHARMD
NOVARTIS INTERNATIONAL, Switzerland
Director, Global HTA Policy
Session 6 – Future of Evidence Workshop: Using Data from Clinical Care for Evidence Generation
Robert Hemmings, MSC
Critical Path Institute, Netherlands